Why China?
GB believes that China has inherent advantages in bio-based industries.
These advantages arise from a strong university system, historical innovation, a workforce high in skill but low in cost, a high level of entrepreneurialism, and a large domestic market. A free research environment, an influx of overseas educated Chinese returning to the mainland, and strengthening IP laws due to WTO accession serve to enhance the growth of this sector in China.
Additional highlights:
China's pharmaceutical and agricultural markets are growing
exponentially
The potential environmental cleanup market is large and forthcoming
legislation will slowly turn potential into reality
China is experiencing massive investment in other sectors
in the economy
The Beijing Genomics Institute participated in the Human
Genome Project
To date there have been several successful product commercializations
by Chinese companies
Shanghai hosted The Human Genome Organisation meeting in
2002
China is a world leader in GMO agriculture
Benefits that are realized in China:
Cost reduction
Revenue lift through entry into the China market
Access to Chinese academia and research innovations
Access to a liberal research environment for stem cell
and in vivo studies
New products based on Traditional Chinese Medicine
